Literature DB >> 11122933

Impulsive aggression in borderline personality disorder.

M Goodman1, A New.   

Abstract

Impulsive aggressive behaviors that include physical aggression directed towards others, self-mutilation, suicide attempts, domestic violence, substance abuse, and property destruction account for a substantial portion of the morbidity and mortality associated with personality disorders, in particular borderline personality disorder (BPD). Recent genetic, neurobiologic, and diagnostic studies suggest a dimensional approach to BPD symptomatology with impulsive aggression as one of the core dimensions for the disorder. The underlying biologic basis for impulsive aggression is centered on the serotonin hypothesis; that central 5-HT function is inversely related to aggression and suicidality. More recent research refines the theory to include associated brain regions, receptor types and neuromodulators potentially involved in the etiology of aggressivity. Treatment utilizes this information with substantial progress in well-designed placebo-controlled studies of selective serotonin reuptake inhibitors such as fluoxetine, and open-label series of atypical neuroleptics, mood stabilizers, and opioid antagonists

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122933     DOI: 10.1007/s11920-000-0043-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  45 in total

1.  Characteristics of borderline personality disorder associated with suicidal behavior.

Authors:  B S Brodsky; K M Malone; S P Ellis; R A Dulit; J J Mann
Journal:  Am J Psychiatry       Date:  1997-12       Impact factor: 18.112

2.  Affective instability and impulsivity in personality disorder. Results of an experimental study.

Authors:  S Herpertz; A Gretzer; E M Steinmeyer; V Muehlbauer; A Schuerkens; H Sass
Journal:  J Affect Disord       Date:  1997-06       Impact factor: 4.839

3.  Reactive hypoglycemic tendency among habitually violent offenders.

Authors:  M Virkkunen
Journal:  Nutr Rev       Date:  1986-05       Impact factor: 7.110

4.  Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.

Authors:  O C Pinto; H S Akiskal
Journal:  J Affect Disord       Date:  1998-12       Impact factor: 4.839

5.  Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study.

Authors:  A S New; J Gelernter; Y Yovell; R L Trestman; D A Nielsen; J Silverman; V Mitropoulou; L J Siever
Journal:  Am J Med Genet       Date:  1998-02-07

Review 6.  Heritability of irritable impulsiveness: a study of twins reared together and apart.

Authors:  E F Coccaro; C S Bergeman; G E McClearn
Journal:  Psychiatry Res       Date:  1993-09       Impact factor: 3.222

Review 7.  Vasopressin and serotonin interactions in the control of agonistic behavior.

Authors:  C F Ferris; Y Delville
Journal:  Psychoneuroendocrinology       Date:  1994       Impact factor: 4.905

8.  Prevalence of personality disorders in two geropsychiatric inpatient units.

Authors:  V Molinari; A Ames; M Essa
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Oct-Dec       Impact factor: 2.680

Review 9.  Genetics in borderline conditions.

Authors:  S Torgersen
Journal:  Acta Psychiatr Scand Suppl       Date:  1994

10.  An open trial of sertraline in personality disordered patients with impulsive aggression.

Authors:  R J Kavoussi; J Liu; E F Coccaro
Journal:  J Clin Psychiatry       Date:  1994-04       Impact factor: 4.384

View more
  15 in total

1.  Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.

Authors:  Andrea Aguglia; Ludovico Mineo; Alessandro Rodolico; Maria S Signorelli; Eugenio Aguglia
Journal:  Int Clin Psychopharmacol       Date:  2018-05       Impact factor: 1.659

Review 2.  Aggression in borderline personality disorder: evidence for increased risk and clinical predictors.

Authors:  Albert Allen; Paul S Links
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 3.  Aggression in borderline personality disorder.

Authors:  K Látalová; J Prasko
Journal:  Psychiatr Q       Date:  2010-09

Review 4.  Past, present, and future of genetic research in borderline personality disorder.

Authors:  Anahita Bassir Nia; Matthew C Eveleth; Jonathan M Gabbay; Yonis J Hassan; Bosi Zhang; M Mercedes Perez-Rodriguez
Journal:  Curr Opin Psychol       Date:  2017-09-12

5.  Emotion dysregulation mediates the relationship between traumatic exposure and aggression in healthy young women.

Authors:  Shannon R Miles; Andra Teten Tharp; Matthew Stanford; Carla Sharp; Deleene Menefee; Thomas A Kent
Journal:  Pers Individ Dif       Date:  2014-12-30

6.  Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder.

Authors:  Michael S McCloskey; Antonia S New; Larry J Siever; Marianne Goodman; Harold W Koenigsberg; Janine D Flory; Emil F Coccaro
Journal:  J Psychiatr Res       Date:  2009-02-18       Impact factor: 4.791

Review 7.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

8.  A quantitative trait locus on chromosome 1 modulates intermale aggression in mice.

Authors:  A Delprato; B Bonheur; M-P Algéo; A Murillo; E Dhawan; L Lu; R W Williams; W E Crusio
Journal:  Genes Brain Behav       Date:  2018-04-27       Impact factor: 3.449

9.  Borderline personality and externalized aggression.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2012-03

10.  The negative affect repair questionnaire: factor analysis and psychometric evaluation in three samples.

Authors:  Anne Scherer; Nicole Eberle; Maren Boecker; Claus Vögele; Siegfried Gauggel; Thomas Forkmann
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.